AMRAD
DEAD

Serial Number

76434045

Owner

AMRAD CORPORATION LIMITED

Attorney

Todd A. Hardy

Filing Date

Jul 23, 2002

Add to watchlist:

No watchlists yet
View on USPTO

AMRAD Trademark

Serial Number: 76434045 • Registration: 2852572

AMRAD is a trademark filed by AMRAD CORPORATION LIMITED on July 23, 2002. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

AMRAD CORPORATION LIMITED (9 trademarks)

KEW V1C 3101 , AU

Entity Type: 03

Trademark Details

Filing Date

July 23, 2002

Registration Date

June 15, 2004

Published for Opposition

March 23, 2004

Cancellation Date

January 21, 2011

Goods & Services

Medical and clinical medical reagents for use in maintaining embryos in culture, increasing embryo implantation, and capture and isolation of DNA, molecular biological reagents for use in the detection of nucleic acid sequences in-vitro; pharmaceutical preparation for human and veterinary use in the treatment of blood disorders, viral disease and nervous system dysfunction, cancer, bone disease, liver disease, cardiac disorders, infertility, pregnancy disorders, and inflammation; diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology

chemical preparations for scientific and research use, namely, proteinaceous reagents for use in maintaining embryos in culture, increasing embryo implantation, and capture and isolation of DNA; reagents for scientific or medical research use, namely, molecular biological reagents for use in the detection of nucleic acid sequences in-vitro and for the expression, isolation and detection of recombination; biochemicals, namely, monoclonal antibodies for in vitro scientific or research use in detecting auto immune disease, microbial disease, protein levels, genetic abnormalities, and pathogens

Medical testing; pharmaceutical advice

Product research and development in the field of drug discovery; research and development for new products for others in the field of drug discovery; medical and scientific research, namely, * conducting clinical trials; biotechnology * consultation and research; pharmaceutical drug development services

Filing History

CANCELLED SEC. 8 (6-YR)
Jan 21, 2011 C8..
CORRECTION UNDER SECTION 7 - PROCESSED
Nov 12, 2004 COC.
SEC 7 REQUEST FILED
Sep 23, 2004 AMD7
PAPER RECEIVED
Sep 23, 2004 MAIL
REGISTERED-PRINCIPAL REGISTER
Jun 15, 2004 R.PR
PUBLISHED FOR OPPOSITION
Mar 23, 2004 PUBO
NOTICE OF PUBLICATION
Mar 3, 2004 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 9, 2003 CNSA
Sec. 1(B) CLAIM DELETED
Dec 9, 2003 1.BD
CASE FILE IN TICRS
Oct 27, 2003 CFIT
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 29, 2003 CRFA
PAPER RECEIVED
Sep 29, 2003 MAIL
LETTER OF SUSPENSION MAILED
May 21, 2003 CNSL
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 29, 2003 CRFA
PAPER RECEIVED
Apr 29, 2003 MAIL
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 9, 2003 CRFA
ASSIGNED TO EXAMINER
Jan 3, 2003 DOCK
NON-FINAL ACTION MAILED
Oct 29, 2002 CNRT
ASSIGNED TO EXAMINER
Oct 22, 2002 DOCK